Immune targeting of cancer stem cells in gastrointestinal oncology

Journal of Gastrointestinal Oncology

Erik Ames¹  Steven K. Grossenbacher¹  William J. Murphy³  Robert J. Canter² 

[1] Laboratory of Cancer Immunology,University of California Davis School of Medicine, Sacramento, CA 95817, USALaboratory of Cancer Immunology,University of California Davis School of Medicine, Sacramento, CA 95817, USALaboratory of Cancer Immunology,University of California Davis School of Medicine, Sacramento, CA 95817, USA;Division of Surgical Oncology,University of California Davis School of Medicine, Sacramento, CA 95817, USADivision of Surgical Oncology,University of California Davis School of Medicine, Sacramento, CA 95817, USADivision of Surgical Oncology,University of California Davis School of Medicine, Sacramento, CA 95817, USA;Laboratory of Cancer Immunology,University of California Davis School of Medicine, Sacramento, CA 95817, USADepartment of Dermatology, University of California Davis School of Medicine, Sacramento, CA 95817, USALaboratory of Cancer Immunology,University of California Davis School of Medicine, Sacramento, CA 95817, USALaboratory of Cancer Immunology,University of California Davis School of Medicine, Sacramento, CA 95817, USADepartment of Dermatology, University of California Davis School of Medicine, Sacramento, CA 95817, USADepartment of Dermatology, University of California Davis School of Medicine, Sacramento, CA 95817, USALaboratory of Cancer Immunology,University of California Davis School of Medicine, Sacramento, CA 95817, USADepartment of Dermatology, University of California Davis School of Medicine, Sacramento, CA 95817, USA

关键词: Cancer stem cells (CSCs);    aldehyde dehydrogenase (ALDH);    CD24;    CD44;    CD133;    immunotherapy;    T cells;    natural killer (NK) cells;    vaccines;    EpCAM;   

DOI  :  10.3978/j.issn.2078-6891.2015.066

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown